cmAngio
FDA Cleared AI for Mammography
Software · Cloud SaaSCompany source
Company profile
About CureMetrix
CureMetrix is a medical imaging AI company specializing in breast cancer detection through advanced artificial intelligence solutions for mammography. The company's flagship product, cmAngio, is an FDA-cleared AI platform designed to assist radiologists in mammography screening and diagnosis. By leveraging sophisticated machine learning algorithms, CureMetrix's technology analyzes mammographic images to help identify potential abnormalities and improve early detection rates of breast cancer. The company focuses on enhancing radiologist workflow efficiency while improving diagnostic accuracy in breast imaging. CureMetrix serves healthcare providers, imaging centers, and health systems seeking to augment their breast cancer screening programs with AI-powered decision support tools. Their solutions are designed to integrate into existing radiology workflows to provide real-time analysis and support for clinical decision-making in mammography interpretation.
Company description CureMetrix official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at CureMetrix?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- breast cancer
Who it serves
- Health Systems
- Imaging Centers
- Radiology Practices
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
A Novel Breast Arterial Calcification Age-Based Percentile Nomogram for the Incremental Prediction of Incidental Cardiovascular Events.JACC. Cardiovascular imaging · Jun 1, 2026
Artificial Intelligence-based Software for Breast Arterial Calcification Detection on Mammograms.Journal of breast imaging · Mar 18, 2025
Potential Impact of an Artificial Intelligence-based Mammography Triage Algorithm on Performance and Workload in a Population-based Screening Sample.Journal of breast imaging · Jan 25, 2025
Automated Breast Arterial Calcification Score Is Associated With Cardiovascular Outcomes and Mortality.JACC. Advances · Nov 1, 2024
Mammographic Breast Density Model Using Semi-Supervised Learning Reduces Inter-/Intra-Reader Variability.Diagnostics (Basel, Switzerland) · Aug 16, 2023
Multicenter, Multivendor Validation of an FDA-approved Algorithm for Mammography Triage.Journal of breast imaging · Oct 10, 2022
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
cmAngio® (V1.6)K250754 · 510k · Apr 10, 2025
cmAngio® V1.0K232367 · 510k · Oct 5, 2023
cmTriageK183285 · 510k · Mar 8, 2019
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from CureMetrix
Recent articles published on CureMetrix's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.